Miao L, Targher G, Byrne CD, Cao YY, Zheng MH (2024) Current status and future trends of the global burden of MASLD. Trends Endocrin Metab 35:697–707. https://doi.org/10.1016/j.tem.2024.02.007

Article  CAS  Google Scholar 

Teng ML, Ng CH, Huang DQ et al (2023) Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol 29:S32–S42. https://doi.org/10.3350/cmh.2022.0365

Article  PubMed  Google Scholar 

Golabi P, Paik JM, AlQahtani S, Younossi Y, Tuncer G, Younossi ZM (2021) Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: data from global burden of disease 2009–2019. J Hepatol 75:795–809. https://doi.org/10.1016/j.jhep.2021.05.022

Article  CAS  PubMed  Google Scholar 

Younossi ZM, Marchesini G, Pinto-Cortez H, Petta S (2019) Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation. Transplantation 103:22–27. https://doi.org/10.1097/tp.0000000000002484

Article  PubMed  Google Scholar 

Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L et al (2015) Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149:367–378. https://doi.org/10.1053/j.gastro.2015.04.005

Article  PubMed  Google Scholar 

Pouwels S, Sakran N, Graham Y et al (2022) Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord 22:63. https://doi.org/10.1186/s12902-022-00980-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leung PB, Davis AM, Kumar S (2023) Diagnosis and management of nonalcoholic fatty liver disease. JAMA 330:1687–1688. https://doi.org/10.1001/jama.2023.17935

Article  PubMed  Google Scholar 

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease (2016). J Hepatol 64:1388–1402. https://doi.org/10.1016/j.jhep.2015.11.004

Musso G, Cassader M, Rosina F, Gambino R (2012) Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 55:885–904. https://doi.org/10.1007/s00125-011-2446-4

Article  CAS  PubMed  Google Scholar 

Slavin JL (2005) Dietary fiber and body weight. Nutrition 21:411–418. https://doi.org/10.1016/j.nut.2004.08.018

Article  PubMed  Google Scholar 

Lattimer JM, Haub MD (2010) Effects of dietary fiber and its components on metabolic health. Nutrients 2:1266–1289. https://doi.org/10.3390/nu2121266

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barber TM, Kabisch S, Pfeiffer AFH, Weickert MO (2020) The health benefits of dietary fibre. Nutrients 12:10. https://doi.org/10.3390/nu12103209

Article  CAS  Google Scholar 

Veronese N, Solmi M, Caruso MG et al (2018) Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses. Am J Clin Nutr 107:436–444. https://doi.org/10.1093/ajcn/nqx082

Article  PubMed  Google Scholar 

Delzenne NM, Neyrinck AM, Cani PD (2013) Gut microbiota and metabolic disorders: how prebiotic can work? Br J Nutr 109(Suppl 2):S81–S85. https://doi.org/10.1017/s0007114512004047

Article  CAS  PubMed  Google Scholar 

Bomhof MR, Paul HA, Geuking MB, Eller LK, Reimer RA (2016) Improvement in adiposity with oligofructose is modified by antibiotics in obese rats. FASEB J 30:2720–2732. https://doi.org/10.1096/fj.201600151R

Article  CAS  PubMed  Google Scholar 

Nicolucci AC, Hume MP, Martínez I, Mayengbam S, Walter J, Reimer RA (2017) Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology 153:711–722. https://doi.org/10.1053/j.gastro.2017.05.055

Article  PubMed  Google Scholar 

Reimer RA, Willis HJ, Tunnicliffe JM, Park H, Madsen KL, Soto-Vaca A (2017) Inulin-type fructans and whey protein both modulate appetite but only fructans alter gut microbiota in adults with overweight/obesity: a randomized controlled trial. Mol Nutr Food Res 61:11. https://doi.org/10.1002/mnfr.201700484

Article  CAS  Google Scholar 

Parnell JA, Reimer RA (2012) Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats. Br J Nutr 107:601–613. https://doi.org/10.1017/s0007114511003163

Article  CAS  PubMed  Google Scholar 

Parnell JA, Reimer RA (2009) Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89:1751–1759. https://doi.org/10.3945/ajcn.2009.27465

Article  CAS  PubMed  Google Scholar 

da Silva TF, Casarotti SN, de Oliveira GLV, Penna ALB (2021) The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts. Crit Rev Food Sci Nutr 61:337–355. https://doi.org/10.1080/10408398.2020.1733483

Article  CAS  PubMed  Google Scholar 

Lambert JE, Parnell JA, Eksteen B et al (2015) Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol. BMC Gastroenterol 15:169. https://doi.org/10.1186/s12876-015-0400-5

Article  PubMed  PubMed Central  Google Scholar 

Bomhof MR, Parnell JA, Ramay HR et al (2019) Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial. Eur J Nutr 58:1735–1745. https://doi.org/10.1007/s00394-018-1721-2

Article  CAS  PubMed  Google Scholar 

Hiel S, Gianfrancesco MA, Rodriguez J et al (2020) Link between gut microbiota and health outcomes in inulin -treated obese patients: lessons from the Food4Gut multicenter randomized placebo-controlled trial. Clin Nutr 39:3618–3628. https://doi.org/10.1016/j.clnu.2020.04.005

Article  CAS  PubMed  Google Scholar 

Moreno C, Mueller S, Szabo G (2019) Non-invasive diagnosis and biomarkers in alcohol-related liver disease. J Hepatol 70:273–283. https://doi.org/10.1016/j.jhep.2018.11.025

Article  PubMed  Google Scholar 

Ratziu V, Massard J, Charlotte F et al (2006) Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 6:6. https://doi.org/10.1186/1471-230x-6-6

Article  PubMed  PubMed Central  Google Scholar 

Blundell J, de Graaf C, Hulshof T et al (2010) Appetite control: methodological aspects of the evaluation of foods. Obesity Rev 11:251–270. https://doi.org/10.1111/j.1467-789X.2010.00714.x

Article  CAS  Google Scholar 

David K, Kowdley KV, Unalp A, Kanwal F, Brunt EM, Schwimmer JB (2009) Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 49:1904–1912. https://doi.org/10.1002/hep.22868

Article  PubMed  Google Scholar 

Gobin G, Shephard RJ (1997) Godin leisure-time excersie questionaire. Med Sci Sports Excerc 29:36–38

Google Scholar 

Mayengbam S, Lambert JE, Parnell JA et al (2019) Impact of dietary fiber supplementation on modulating microbiota-host-metabolic axes in obesity. J Nutr Biochem 64:228–236. https://doi.org/10.1016/j.jnutbio.2018.11.003

Article  CAS  PubMed  Google Scholar 

Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. https://doi.org/10.1093/bioinformatics/btu170

Article  CAS  PubMed  PubMed Central  Google Scholar 

Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP (2016) DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 13:581–583. https://doi.org/10.1038/nmeth.3869